Log in to save to my catalogue

Reactive Oxygen Signaling and MAPK Activation Distinguish Epstein-Barr Virus (EBV)-Positive versus E...

Reactive Oxygen Signaling and MAPK Activation Distinguish Epstein-Barr Virus (EBV)-Positive versus E...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_544042

Reactive Oxygen Signaling and MAPK Activation Distinguish Epstein-Barr Virus (EBV)-Positive versus EBV-Negative Burkitt's Lymphoma

About this item

Full title

Reactive Oxygen Signaling and MAPK Activation Distinguish Epstein-Barr Virus (EBV)-Positive versus EBV-Negative Burkitt's Lymphoma

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (1), p.175-179

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Burkitt's lymphoma (BL) is an aggressive B cell neoplasm, which is one of the most common neoplasms of childhood. It is highly widespread in East Africa, where it appears in endemic form associated with Epstein-Barr virus (EBV) infection, and around the world in a sporadic form in which EBV infection is much less common. In addition to being the fi...

Alternative Titles

Full title

Reactive Oxygen Signaling and MAPK Activation Distinguish Epstein-Barr Virus (EBV)-Positive versus EBV-Negative Burkitt's Lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_544042

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_544042

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0408381102

How to access this item